Syndax Pharmaceuticals Inc (SNDX) Insider Ownership

Historic Insider Ownership Trends

SNDX's three largest insider shareholders as of April 17, 2026 are Michael A Metzger (Chief Executive Officer, 491.69K shares), Dennis Podlesak (Director, 239.76K shares), Keith A. Goldan (Chief Financial Officer, 140.43K shares).

Top Direct Holders

Insider ownership data is derived from the last 60 months of Form 4 SEC filings.
Holder Position Shares (Direct) Shares (Indirect) Report Date
Michael A Metzger Chief Executive Officer 491,690 0 10 Feb, 2026
Dennis Podlesak - 239,763 0 06 Feb, 2026
Keith A. Goldan Chief Financial Officer 140,429 0 10 Feb, 2026
Keith Katkin - 124,000 0 06 Feb, 2026
Jennifer Jarrett - 114,000 0 06 Feb, 2026
Pierre Legault - 114,000 0 06 Feb, 2026
Martin H. Jr. Huber - 103,000 0 06 Feb, 2026
Nicholas A.J. Botwood Head Of Rd, Cmo 95,165 0 06 Feb, 2026
William Meury - 90,000 0 07 Feb, 2025
Neil Gallagher President, Head Of Rd 85,095 0 12 Feb, 2025
Aleksandra Rizo - 49,000 0 06 Feb, 2026
Briggs Morrison President, Head Of Rd 34,836 0 09 Feb, 2024
Fabrice Egros - 32,000 0 03 Feb, 2022
Michael L. Meyers Svp, Chief Medical Officer 23,280 0 03 Feb, 2022

* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.

Recent Insider Transactions

Detailed insider trading activity based on Form 4 SEC filings.
Download Data
Transaction Date Insider Name Security Class Transaction Type Shares Traded Price Shares Remaining Ownership Code
09 Feb, 2026 Michael A Metzger Common Stock D 17,159 $21.03 491,690 D S
09 Feb, 2026 Keith A. Goldan Common Stock D 3,410 $21.03 140,429 D S
04 Feb, 2026 Michael A Metzger Common Stock A 73,000 $0.00 371,661 D A
04 Feb, 2026 Aleksandra Rizo Common Stock A 24,000 $0.00 49,000 D A
04 Feb, 2026 Keith Katkin Common Stock A 24,000 $0.00 124,000 D A
30 Jan, 2026 Keith A. Goldan Common Stock A 1,219 $8.48 93,671 D J
04 Feb, 2026 Martin H. Jr. Huber Common Stock A 24,000 $0.00 103,000 D A
04 Feb, 2026 Nicholas A.J. Botwood Common Stock A 24,000 $0.00 59,165 D A
04 Feb, 2026 Jennifer Jarrett Common Stock A 24,000 $0.00 114,000 D A
04 Feb, 2026 Dennis Podlesak Common Stock A 48,000 $0.00 239,763 D A
04 Feb, 2026 Pierre Legault Common Stock A 24,000 $0.00 114,000 D A
04 Feb, 2026 Nicholas A.J. Botwood Common Stock A 36,000 $0.00 95,165 D A
04 Feb, 2026 Michael A Metzger Common Stock A 144,600 $0.00 516,261 D A
04 Feb, 2026 Keith A. Goldan Common Stock A 21,500 $0.00 115,171 D A
04 Feb, 2026 Nicholas A.J. Botwood Stock Options (Right to buy) A 144,700 $20.43 144,700 D A
04 Feb, 2026 Keith A. Goldan Common Stock A 30,750 $0.00 145,921 D A
06 Feb, 2026 Michael A Metzger Common Stock D 7,412 $20.62 508,849 D S
06 Feb, 2026 Keith A. Goldan Common Stock D 2,082 $20.62 143,839 D S
04 Feb, 2026 Michael A Metzger Stock Options (Right to buy) A 440,000 $20.43 440,000 D A
04 Feb, 2026 Keith A. Goldan Stock Options (Right to buy) A 118,000 $20.43 118,000 D A